Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.

Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.

Show other versions (1)

OBJECTIVES: To investigate the function-structure relationship of white matter within different stages of Huntington's disease (HD) using diffusion tensor imaging (DTI). EXPERIMENTAL DESIGN: From the TRACK-HD study, an early stage HD group and a premanifest gene carrier group (PMGC) were age-m...

Full description

Bibliographic Details
Main Authors:	Dumas, E, van den Bogaard, S, Ruber, M, Reilman, R, Stout, J, Craufurd, D, Hicks, S, Kennard, C, Tabrizi, S, Buchem, v, van der Grond, J, Roos, R
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease
by: Dumas, E, et al.
Published: (2011)

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
by: Scahill, R, et al.
Published: (2013)

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy
by: Scahill, R, et al.
Published: (2013)

OCULOMOTOR DEFICITS IN PREMANIFEST AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES: THE LONGITUDINAL TRACK-HD STUDY
by: Hicks, S, et al.
Published: (2012)

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
by: Tabrizi, S, et al.
Published: (2011)

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
by: Tabrizi, S, et al.
Published: (2012)

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
by: Tabrizi, S, et al.
Published: (2011)

SIGNIFICANT BIOLOGICAL AND CLINICAL CHANGE DETECTED OVER 1 YEAR IN PREMANIFEST AND EARLY STAGE HUNTINGTON'S DISEASE IN THE TRACK-HD STUDY
by: Tabrizi, S, et al.
Published: (2010)

SIGNIFICANT BIOLOGICAL AND CLINICAL CHANGE DETECTED OVER 1 YEAR IN PREMANIFEST AND EARLY STAGE HUNTINGTON'S DISEASE IN THE TRACK-HD STUDY
by: Tabrizi, S, et al.
Published: (2010)

Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice.
by: Jessica Y Winder, et al.
Published: (2018-01-01)

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
by: Paul Zeun, et al.
Published: (2022-01-01)

Linking white matter and deep gray matter alterations in premanifest Huntington disease
by: Andreia V. Faria, et al.
Published: (2016-01-01)

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
by: Nicola Pavese, et al.
Published: (2010-02-01)

Motor cortex plasticity response to acute cardiorespiratory exercise and intermittent theta-burst stimulation is attenuated in premanifest and early Huntington’s disease
by: Sophie C. Andrews, et al.
Published: (2022-01-01)

Huntington disease: from premanifest to diagnosis and early care
by: Elizabeth A McCusker
Published: (2019-01-01)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
by: Beatrice Heim, et al.
Published: (2020-11-01)

Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation.
by: Lauren M Turner, et al.
Published: (2015-01-01)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
by: Giulia D’Aurizio, et al.
Published: (2019-04-01)

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
by: Marios Politis, et al.
Published: (2015-11-01)

Lumbar puncture safety and tolerability in premanifest and manifest Huntington’s disease: a multi-analysis cross-sectional study
by: Yara Refaat Hassan, et al.
Published: (2022-11-01)

Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease
by: Eduardo Castro, et al.
Published: (2018-01-01)

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
by: Juan F Domínguez D, et al.
Published: (2013-01-01)

A single bout of moderate-intensity aerobic exercise improves motor learning in premanifest and early Huntington’s disease
by: Sophie C. Andrews, et al.
Published: (2023-03-01)

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
by: Tabrizi, S, et al.
Published: (2009)

Diffusion MRI in premanifest Huntington's disease and early Parkinson's disease: tensor and tractography analyses
by: Pflanz, C
Published: (2019)

Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease
by: Marina Herrero‐Lorenzo, et al.
Published: (2024-10-01)

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
by: Travis Cruickshank, et al.
Published: (2021-03-01)

The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington’s disease individuals
by: Filipa Júlio, et al.
Published: (2019-11-01)

The relationship between non-motor features and weight-loss in the premanifest stage of Huntington's disease.
by: Wasiq Khan, et al.
Published: (2021-01-01)

Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease
by: Danielle M. Bartlett, et al.
Published: (2019-01-01)

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study
by: Verena Baake, et al.
Published: (2018-01-01)

Associations between Sleep Quality and Serum Levels of Neurofilament Light in Individuals with Premanifest Huntington Disease
by: Mitchell Turner, et al.
Published: (2024-06-01)

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing
by: Elizabeth A. McCusker, et al.
Published: (2017-09-01)

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset
by: Rahel Dominique Schmid, et al.
Published: (2022-06-01)

Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease
by: Chiara Casella, et al.
Published: (2021-01-01)

OCULOMOTOR DEFICITS IN PRESYMPTOMATIC AND EARLY HUNTINGTON'S DISEASE AND THEIR STRUCTURAL BRAIN CORRELATES
by: Hicks, S, et al.
Published: (2010)

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.
by: Valter Niemelä, et al.
Published: (2018-01-01)

Corrigendum to “Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers” [Neurobiol. Dis. 83 (2015) 115–121]
by: Marios Politis, et al.
Published: (2017-02-01)

Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington’s disease
by: Beini Hu, et al.
Published: (2023-01-01)

Shifting focus from ideality to reality: a qualitative study on how quality of life is defined by premanifest and manifest Huntington’s disease gene expansion carriers
by: Pearl J. C. van Lonkhuizen, et al.
Published: (2024-11-01)